Six products from Joonghun Pharmaceutical’s Lorient line, a group of cross-linked hyaluronic acid-dermal fillers, have been CE marked.

Hyaluronic acid is a substance that is present in the human skin, skeleton and synovial fluid, and has lubrication and moisturizing properties.

The dermal fillers are designed to be injected into the subcutaneous layer of the skin to temporarily reduce facial wrinkles in adults. Three of the products include lidocaine, a local anesthetic.